Wen Zhou

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Angiotensin Converting Enzyme

Acute Ischemic Stroke

Replacement Therapy

Top Venues

Journal of medicinal chemistry

Journal of drug targeting

Cardiovascular drugs and therapy

Nanjing University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Nanjing University

China

PHD

Publications

Wen Zhou, Wanxiang Yang, Ping Jiang, Shaohua Gou
A Lysosome-Targeting hNEU1 Inhibitor Treats Myocardial Infarction: A Potential Therapeutic Breakthrough. Journal of medicinal chemistry (2024)
Wanxiang Yang, Wen Zhou, Shaohua Gou
Discovery of Efficient Hypoxia-Targeted NO Donor Compounds to Alleviate Hypoxia Cardiac Disease. Journal of medicinal chemistry (2023)
Wen Zhou, Chunping Wang, Zhikun Liu, Shaohua Gou
Hypoxia-Activated Prodrugs with Dual COX-2/CA Inhibitory Effects on Attenuating Cardiac Inflammation under Hypoxia. Journal of medicinal chemistry 65 (19) (2022)
Wen Zhou, Bin Zhang, Keyu Fan, Xiaojian Yin, Jinfeng Liu, Shaohua Gou
An Original Aspirin-Containing Carbonic Anhydrase 9 Inhibitor Overcomes Hypoxia-Induced Drug Resistance to Enhance the Efficacy of Myocardial Protection. Cardiovascular drugs and therapy (2021)
Yun-Peng Zhao, Fei Wang, Wei Jiang, Jinfeng Liu, Bao-Lin Liu, Lian-Wen Qi, Wen Zhou
A mitochondrion-targeting tanshinone IIA derivative attenuates myocardial hypoxia reoxygenation injury through a SDH-dependent antioxidant mechanism. Journal of drug targeting 27 (8) (2019)